Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Acta Neurol Scand. 2021 Mar;143(3):303-312. doi: 10.1111/ane.13366. Epub 2020 Dec 4.
The cause of ischemic stroke remains unknown, cryptogenic, in 25% of young and middle-aged patients. We hypothesized that if atherosclerosis is prominent in cryptogenic stroke, it would have a similar proinflammatory protein signature as large artery atherosclerosis (LAA) stroke.
MATERIALS & METHODS: Blood was collected in the acute phase and after 3 months from cryptogenic (n = 162) and LAA (n = 73) stroke patients aged 18-69 years and once from age-matched controls (n = 235). Cryptogenic stroke was divided into Framingham Risk Score (FRS) quartiles to compare low and high risk of atherosclerosis. Plasma concentrations of 25 proteins were analyzed using a Luminex multiplex assay. The discriminating properties were assessed with discriminant analysis and C-statistics.
We identified proteins that separated cryptogenic and LAA stroke from controls (area under the curves, AUCs ≥ 0.85). For both subtypes, RANTES, IL-4, and IFN-γ contributed the most at both time points. These associations were independent of risk factors of atherosclerosis. We also identified proteins that separated cryptogenic strokes in the lowest quartile of FRS from those in the highest, and from LAA stroke (AUCs ≥ 0.76), and here eotaxin and MCP-1 contributed the most.
The protein signature separating cases from controls was different from the signature separating cryptogenic stroke with low risk of atherosclerosis from those with high risk and from LAA stroke. This suggests that increased RANTES, IL-4, and IFN-γ in stroke may not be primarily related to atherosclerosis, whereas increased eotaxin and MCP-1 in cryptogenic stroke may be markers of occult atherosclerosis as the underlying cause.
在 25%的年轻和中年缺血性卒中患者中,病因不明,为隐源性。我们假设,如果隐源性卒中的动脉粥样硬化明显,其促炎蛋白特征与大动脉粥样硬化(LAA)卒中相似。
在急性发作后 3 个月内,采集 18-69 岁隐源性(n=162)和 LAA(n=73)卒中患者以及年龄匹配对照者(n=235)的血液。将隐源性卒中分为弗雷明汉风险评分(FRS)四分位数,以比较动脉粥样硬化的低危和高危。使用 Luminex 多重分析测定法分析 25 种蛋白的血浆浓度。使用判别分析和 C 统计量评估判别特性。
我们确定了能够区分隐源性和 LAA 卒中与对照组的蛋白(曲线下面积,AUCs≥0.85)。对于两种亚型,RANTES、IL-4 和 IFN-γ 在两个时间点的贡献最大。这些相关性独立于动脉粥样硬化的危险因素。我们还确定了能够区分 FRS 最低四分位数的隐源性卒中与最高四分位数的隐源性卒中以及 LAA 卒中的蛋白(AUCs≥0.76),在这里,趋化因子 eotaxin 和单核细胞趋化蛋白-1 贡献最大。
区分病例与对照的蛋白特征与区分低危和高危隐源性卒中与 LAA 卒中的特征不同。这表明,卒中时 RANTES、IL-4 和 IFN-γ 的增加可能主要与动脉粥样硬化无关,而隐源性卒中时趋化因子 eotaxin 和单核细胞趋化蛋白-1 的增加可能是隐匿性动脉粥样硬化作为潜在病因的标志物。